EVALUATION OF THE EFFECT OF METFORMIN ON SERUM INFLAMMATORY BIOMARKERS (CRP, IL-6) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. RMSR [Internet]. 2025 May 29 [cited 2025 Jul. 17];3(5):982-7. Available from: https://www.thermsr.com/index.php/Journal/article/view/1235